Innoviva (INVA) News Today → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free INVA Stock Alerts $15.98 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 17 at 8:27 AM | marketbeat.comBoston Partners Lowers Holdings in Innoviva, Inc. (NASDAQ:INVA)Boston Partners trimmed its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 47.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 205,672 shares of the biotechnology company's stock after selling 1May 16 at 7:56 AM | marketbeat.comJump Financial LLC Raises Stock Position in Innoviva, Inc. (NASDAQ:INVA)Jump Financial LLC raised its position in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 281.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 91,995 shares of the biotechnology company's stock after purchasing an additioMay 10, 2024 | finance.yahoo.comInnoviva Inc (INVA) Reports First Quarter 2024 Earnings: A Detailed AnalysisMay 10, 2024 | finance.yahoo.comInnoviva First Quarter 2024 Earnings: EPS: US$0.58 (vs US$0.51 in 1Q 2023)May 8, 2024 | investorplace.comINVA Stock Earnings: Innoviva Beats EPS, Beats Revenue for Q1 2024May 8, 2024 | businesswire.comInnoviva to Participate in the BofA Securities Health Care ConferenceApril 29, 2024 | marketbeat.com68,000 Shares in Innoviva, Inc. (NASDAQ:INVA) Acquired by Chase Investment Counsel CorpChase Investment Counsel Corp bought a new position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 68,000 shares of the biotechnolApril 24, 2024 | finance.yahoo.comInnoviva Specialty Therapeutics’ Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024April 24, 2024 | businesswire.comInnoviva Specialty Therapeutics' Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024April 23, 2024 | marketbeat.comAllspring Global Investments Holdings LLC Trims Position in Innoviva, Inc. (NASDAQ:INVA)Allspring Global Investments Holdings LLC lowered its position in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 36.8% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 96,064 shares of the biotechnology company's stock after selling 55,980 shares during the peApril 22, 2024 | finance.yahoo.comShould Weakness in Innoviva, Inc.'s (NASDAQ:INVA) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?April 22, 2024 | marketbeat.comInnoviva, Inc. (NASDAQ:INVA) Shares Sold by Hussman Strategic Advisors Inc.Hussman Strategic Advisors Inc. decreased its position in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 49.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 105,000 shares of the biotechApril 14, 2024 | marketbeat.comInnoviva, Inc. (NASDAQ:INVA) Sees Large Drop in Short InterestInnoviva, Inc. (NASDAQ:INVA - Get Free Report) was the target of a large decrease in short interest in March. As of March 31st, there was short interest totalling 11,330,000 shares, a decrease of 13.0% from the March 15th total of 13,020,000 shares. Currently, 18.2% of the company's stock are short sold. Based on an average trading volume of 681,300 shares, the days-to-cover ratio is currently 16.6 days.April 6, 2024 | marketbeat.comVanguard Group Inc. Decreases Stock Position in Innoviva, Inc. (NASDAQ:INVA)Vanguard Group Inc. trimmed its holdings in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 1.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,717,437 shares of the biotechnology company's stock aMarch 29, 2024 | marketbeat.comInnoviva (NASDAQ:INVA) Upgraded by StockNews.com to BuyStockNews.com raised Innoviva from a "hold" rating to a "buy" rating in a research note on Friday.March 26, 2024 | marketbeat.comPacer Advisors Inc. Buys 1,727,534 Shares of Innoviva, Inc. (NASDAQ:INVA)Pacer Advisors Inc. boosted its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 119,140.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,728,984 shares of the biotechnology company's stock after acquirMarch 21, 2024 | marketbeat.comInnoviva (NASDAQ:INVA) Cut to Hold at StockNews.comStockNews.com downgraded Innoviva from a "buy" rating to a "hold" rating in a report on Thursday.March 18, 2024 | marketbeat.comInnoviva, Inc. (NASDAQ:INVA) Sees Large Growth in Short InterestInnoviva, Inc. (NASDAQ:INVA - Get Free Report) was the recipient of a large increase in short interest in February. As of February 29th, there was short interest totalling 13,320,000 shares, an increase of 7.9% from the February 14th total of 12,350,000 shares. Based on an average daily volume of 747,400 shares, the days-to-cover ratio is currently 17.8 days. Approximately 21.3% of the shares of the company are short sold.March 9, 2024 | marketbeat.comInvesco Ltd. Raises Position in Innoviva, Inc. (NASDAQ:INVA)Invesco Ltd. grew its position in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 55.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 661,978 shares of the biotechnology company's stock aMarch 8, 2024 | benzinga.comInsider Decision Unfolding At Innoviva: Pavel Raifeld Exercises OptionsMarch 4, 2024 | msn.comArmata enters $35M credit agreement with InnovivaFebruary 29, 2024 | finance.yahoo.comInnoviva Reports Fourth Quarter and Full Year 2023 Financial Results; Highlights Recent Company ProgressFebruary 29, 2024 | businesswire.comInnoviva Reports Fourth Quarter and Full Year 2023 Financial Results; Highlights Recent Company ProgressFebruary 29, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Increases Position in Innoviva, Inc. (NASDAQ:INVA)Charles Schwab Investment Management Inc. raised its stake in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 16.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 797,803 shares of the biotechnology company's sFebruary 28, 2024 | msn.com10 stocks you can bet on being inflation-proofFebruary 28, 2024 | marketbeat.comWestfield Capital Management Co. LP Grows Position in Innoviva, Inc. (NASDAQ:INVA)Westfield Capital Management Co. LP boosted its holdings in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 6.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,045,010 shares of the biotechnology company's stockFebruary 25, 2024 | marketbeat.com42,400 Shares in Innoviva, Inc. (NASDAQ:INVA) Acquired by OMERS ADMINISTRATION CorpOMERS ADMINISTRATION Corp acquired a new position in Innoviva, Inc. (NASDAQ:INVA - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 42,400 shares of the biotechnology company'sFebruary 23, 2024 | marketbeat.comQRG Capital Management Inc. Takes $731,000 Position in Innoviva, Inc. (NASDAQ:INVA)QRG Capital Management Inc. purchased a new stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 56,243 shares of the biotechnology company's stock, valued at approximatelyFebruary 14, 2024 | finance.yahoo.comJim Simons Bolsters Position in Innoviva Inc with Recent AcquisitionFebruary 8, 2024 | morningstar.comInnoviva Inc INVAFebruary 6, 2024 | morningstar.comCosmo Pharmaceuticals NV COPNFebruary 6, 2024 | marketbeat.comBoston Partners Has $5.11 Million Stake in Innoviva, Inc. (NASDAQ:INVA)Boston Partners boosted its position in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 10.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 393,470 shares of the biotechnology company's stock after buyFebruary 5, 2024 | marketbeat.comIllinois Municipal Retirement Fund Takes $431,000 Position in Innoviva, Inc. (NASDAQ:INVA)Illinois Municipal Retirement Fund bought a new stake in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 33,148 shares of the bioteJanuary 31, 2024 | marketbeat.comInnoviva, Inc. (NASDAQ:INVA) Sees Large Decline in Short InterestInnoviva, Inc. (NASDAQ:INVA - Get Free Report) saw a large drop in short interest during the month of January. As of January 15th, there was short interest totalling 11,800,000 shares, a drop of 6.8% from the December 31st total of 12,660,000 shares. Based on an average daily trading volume, of 755,800 shares, the days-to-cover ratio is presently 15.6 days. Approximately 22.3% of the shares of the company are short sold.January 27, 2024 | marketbeat.comBank of New York Mellon Corp Sells 204,961 Shares of Innoviva, Inc. (NASDAQ:INVA)Bank of New York Mellon Corp decreased its holdings in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 21.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 729,904 shares of the biotechnology comJanuary 25, 2024 | stocknews.com3 Lucrative Biotech Stock Buys for SuccessJanuary 24, 2024 | marketbeat.comAllspring Global Investments Holdings LLC Trims Stake in Innoviva, Inc. (NASDAQ:INVA)Allspring Global Investments Holdings LLC trimmed its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 30.3% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 152,044 shares of the biotechnology companyJanuary 8, 2024 | msn.comChart of the Day: Innoviva - Individual Investor FavoriteDecember 30, 2023 | finance.yahoo.comInnoviva's (NASDAQ:INVA) investors will be pleased with their 29% return over the last three yearsDecember 28, 2023 | marketbeat.comExchange Traded Concepts LLC Has $2.04 Million Stock Position in Innoviva, Inc. (NASDAQ:INVA)Exchange Traded Concepts LLC cut its stake in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 10.8% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 156,958 shares of the biotechnology company's stock after selling 18,930 sharDecember 21, 2023 | uk.finance.yahoo.comInnoviva, Inc. (INVA) stock historical prices & data – Yahoo FinanceDecember 11, 2023 | stocknews.comAnalyzing the Bullish Opportunities of 3 Biotech StocksNovember 27, 2023 | msn.comInnoviva (INVA) Price Target Increased by 7.14% to 15.30November 18, 2023 | finance.yahoo.comInsider Sell Alert: Marianne Zhen Offloads Shares of Innoviva IncNovember 14, 2023 | finance.yahoo.comInnoviva, Inc. (NASDAQ:INVA) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?November 3, 2023 | finance.yahoo.comInnoviva Inc (INVA) Reports Q3 2023 Financial Results: Net Income Drops to $82.0 MillionNovember 1, 2023 | finance.yahoo.comPositive Results Announced in Largest Pivotal Phase 3 Trial of a First-in-Class Oral Antibiotic to Treat Uncomplicated GonorrheaNovember 1, 2023 | finance.yahoo.comInnoviva Reports Third Quarter 2023 Financial Results and Highlights Recent Company ProgressOctober 18, 2023 | finance.yahoo.comCalculating The Intrinsic Value Of Innoviva, Inc. (NASDAQ:INVA)October 9, 2023 | seekingalpha.comInnoviva: A Lot Of Moving Parts Get Innoviva News Delivered to You Automatically Sign up to receive the latest news and ratings for INVA and its competitors with MarketBeat's FREE daily newsletter. Email Address The Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm. Click here to access the Crypto Retirement Blueprint now. INVA Media Mentions By Week INVA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INVA News Sentiment▼1.080.50▲Average Medical News Sentiment INVA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INVA Articles This Week▼21▲INVA Articles Average Week Get Innoviva News Delivered to You Automatically Sign up to receive the latest news and ratings for INVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Ironwood Pharmaceuticals News OPKO Health News MannKind News Kiniksa Pharmaceuticals News Phathom Pharmaceuticals News Dynavax Technologies News Ligand Pharmaceuticals News Lexicon Pharmaceuticals News Theravance Biopharma News Supernus Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INVA) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & CompanyThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMost important medical advance in 100 yearsThe Oxford ClubThe Presidential candidate you should REALLY be worried aboutStansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsClaim Your Complimentary Bitcoin RewardCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innoviva, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
